Riskpilot← Back to searchSign inGet full accessSURCON CARE LINE ApS
APSActiveCVR 26756162Baunevej 7Wholesale of pharmaceutical and medical goods · NACE 4646Est. 20021 employees
Revenue 2024
DKK 570K
+78% vs 2023
EBITDA margin
25.7%
+278% vs 2023
Equity ratio
-10.7%
Financial strength
Net profit 2024
DKK 89K
+165% vs 2023
| Revenue | DKK 570K | +78% |
| EBITDA | DKK 146K | +278% |
| Net profit | DKK 89K | +165% |
| Total assets | DKK 762K | -5% |
| Equity | DKK -81K | +52% |
| Employees | 1 | — |
Legal name
SURCON CARE LINE ApS
CVR number
26756162
Legal form
Anpartsselskab
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
22. august 2002
Share capital
DKK 250.000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af direktionen.
Company purpose
Selskabets formål er at drive handel og industri og dermed beslægtet virksomhed
Address
Baunevej 7
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 500 | 282 | 406 | 320 | 570 |
| Staff expenses | -627 | -543 | -450 | -402 | -423 |
| EBITDA | -127 | -260 | -44 | -82 | 146 |
| Depreciation & amort. | -0 | -0 | -0 | -0 | -0 |
| EBIT | -127 | -260 | -44 | -82 | 146 |
| Net financials | -5 | -28 | -40 | -55 | -56 |
| Profit before tax | -132 | -289 | -84 | -137 | 90 |
| Tax | -0 | -0 | -1 | -0 | 2 |
| Net profit | -132 | -289 | -83 | -137 | 89 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 1.079 | 869 | 818 | 801 | 762 |
| Equity | 339 | 50 | -33 | -170 | -81 |
| Long-term debt | 0 | 0 | 157 | 149 | 0 |
| Short-term debt | 740 | 819 | 693 | 822 | 843 |
| Total debt | 740 | 819 | 850 | 971 | 843 |
EBITDA margin
25.7%
This company
15.8%
Market median
+63% vs market
20202024
Equity ratio
-10.7%
This company
38.2%
Market median
-128% vs market
20202024
Return on equity
8856900.0%
This company
18.4%
Market median
+48135226% vs market
20202024
Net profit margin
15.5%
This company
8.1%
Market median
+91% vs market
20202024
Asset turnover
0.75×
This company
1.12×
Market median
-33% vs market
20202024
Debt / equity
10.38×
This company
0.62×
Market median
-1574% vs market
20202024
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Former (4) | ||
BC Audit | Audit | 2002 – 2008 |
KM Management | Management | 2002 – 2002 |
VJ Management | Management | 2002 – 2015 |
LV Management | Management | 2002 – 2005 |
No data on file.
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Individual | 100% | 100% | 2014 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of SURCON CARE LINE ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Bent Christensen | Audit | 0 companies |
| Kim Madsen | Management | 0 companies |
| Villy Jensen | Management | 0 companies |
| Lars Voldby-Jensen | Management | 0 companies |